Commentary | Published:

A “complement–ary” AIDS vaccine

Nature Medicine volume 2, pages 153155 (1996) | Download Citation

Subjects

The human immunodeficiency virus uses the human complement system to its advantage. Is it possible to turn the tables with a vaccine?

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , , & Separation of self from non-self in the complement system. A role for membrane cofactor protein and decay accelerating factor. Clin. Exp. Immun. 86, 27–30 (1991).

  2. 2.

    et al. Barriers to xenotransplantation. Nature Med. 1, 869–873 (1995).

  3. 3.

    & The generation of transgenic pigs as potential organ donors for humans. Nature Med. 1, 964–966 (1995).

  4. 4.

    et al. HIV and human complement: Mechanisms of interaction and biological implications. Immunol. Today 14, 435–440 (1993).

  5. 5.

    , , , & Efficient destruction of HIV in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55). J. Exp. Med. (in the press).

  6. 6.

    , , & Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur. J. Immunol. 25, 285–290 (1995).

  7. 7.

    et al. Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell-line derived and primary isolates of HIV 1. J. Exp. Med. 182, 501–509 (1995).

  8. 8.

    Assembly and morphology of HIV: Potential effect of structure on viral function. AIDS 5, 617–637 (1991).

  9. 9.

    et al. Cellular proteins bound to immunodeficiency viruses: implication for pathogenesis and vaccines. Science 258, 1935–1938 (1992).

  10. 10.

    & Association of host cell surface adhesion receptors and other membrane proteins with HIV and SIV. AIDS Res. Hum. Retrovir. 9, 1157–1165 (1993).

  11. 11.

    & Membrane proteins that protect against complement lysis. Immuno-pathology 15, 369–396 (1994).

  12. 12.

    , , & Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174, 944–952 (1991).

  13. 13.

    , , , & The envelope glycoprotein of HIV-1 gp120 and the human complement protein Clq bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenetic homology. Eur. J. Immunol. 24, 294–300 (1994).

  14. 14.

    et al. Complement receptors: Another port of entry for HIV. Lancet ii, 271–272 (1989).

  15. 15.

    et al. Complement-mediated enhancement of HIV-1 infection of the monoblastoid cell line U937. AIDS 4, 961–965 (1989).

  16. 16.

    , , & Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus carrying B cells. Exp. Med. 171, 1791–1796 (1990).

  17. 17.

    , , , & Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4-and antibody-independent fashion. J. Exp. Med. 173, 1151–1158 (1991).

  18. 18.

    , & Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors. Virology 175, 600–604 (1990).

  19. 19.

    et al. Binding of human immunodeficiency virus type 1 to follicular dendritic cells in vitro is complement dependent. J. Immunol. 150, 1065–1073 (1993).

  20. 20.

    , , & Direct interaction of complement factor H with the C1 domain of HIV-1 gp120. AIDS Res. Hum. Retrovir. 11, 577–588 (1995).

  21. 21.

    , , , & Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS 9, 19–26 (1995).

  22. 22.

    , , , & HIV gp41 and complement factor H interact with each other and share functional as well as antigenic homology. AIDS Res. Hum. Retrovir. 11, 971–980 (1995).

  23. 23.

    , , & Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology 193, 98–113 (1995).

  24. 24.

    & Complement deficiency and diseases. Immunol. Today 12, 301–306 (1991).

  25. 25.

    Biology of complement: The overture. Immunol. Today 12, 291–295 (1991).

  26. 26.

    & Complement lysis: A hole is a hole. Immunol. Today 12, 318–320 (1991).

Download references

Author information

Affiliations

  1. Institut für Hygiene and Ludwig, Boltzmann-Institut für AIDS-Forschung, Innsbruck, Austria

    • Manfred P. Dierich
    •  & Heribert Stoiber
  2. Laboratorio Interdisciplinare Tecnologie Avanzate, Universit egli Studi di Milano, Italy

    • Alberto Clivio

Authors

  1. Search for Manfred P. Dierich in:

  2. Search for Heribert Stoiber in:

  3. Search for Alberto Clivio in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm0296-153

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing